
Patient Validated Antibodies
ProSci has validated antibodies by IHC with COVID-19 positive patient tissue samples, showing that these antibodies can detect the virus itself.
ACE2 Ab (3217) Cited in Cell
SARS-CoV-2 Spike Ab 3525 Cited in
Nature Microbiology
COVID-19 (SARS-CoV-2, 2019-nCoV) Research
ProSci Incorporated has developed and manufactured SARS-CoV-2 (COVID-19, 2019-nCoV) antibodies, antigens, and other reagents related to cellular entry: ACE2 receptor, TMPRSSR2 protease, and furin enzyme. ProSci Inc. is continuously adding new SARS-CoV-2 reagents for spike, S1, S2, nucleocapsid, membrane, envelope including llama single domain antibodies and recombinant proteins. We have SARS-CoV-2 (2019-nCoV) recombinant proteins, COVID-19 patient sample validated antibodies, and are actively developing new coronavirus products. In addition, our custom antibody services support SARS-CoV-2 research in the development of research tools, diagnostics, therapeutics and vaccines.
Featured Products
|
||
Nucleocapsid AB Cat No. 9099 Spike S1 Ab Cat No. 9083 |
SARS-CoV-2 (COVID-19) Spike S2 Ab Cat No. 3525 in Nose, Lung, and Skin | MANF Ab Cat No. 4347 |
New Products
IRF-7 Ab Cat No. 8991 | hRIP3 Ab Cat No. 8963 | CDKN2A Ab Cat No. 8975 |
Products with Citations
mRIP3 AB Cat No. 2283 Cited in Cell, Nature, Nature Medicine |
BACE Ab Cat No. 2253 Cited in Nature Neuroscience |
CX3CR1 Ab Cat No. 2093 Cited in Circulation, Blood |
Citations
Antibody Products
Antibody Research

5A's Antibody Guide
Inside our antibody development guide section, you will find information about how our custom antibody services work, the challenges we face, and how we resolve them.

San Diego Company
ProSci is proud to be a local San Diego antibody company devoted to R&D and committed to design, development and production of high performance antibodies.

ProSci Blog
Learn more about ProSci's experience with creating antibodies for difficult antigens and new developments in antibody research through our blog posts.